As value investors, we try to buy stocks at undervalued prices. Guru Bargains are a good place to look for ideas. This week’s highlight: USEC Inc. (USU), Angiotech Pharmaceuticals Inc. (ANPI), Ruby Tuesday Inc. (RT), Stein Mart Inc. (SMRT), Wabash National Corp. (WNC).
USEC Inc. (USU): Down 46% Since John Keeley Bought In the Third Quarter
John Keeley initiated holdings in Electricity company USEC Inc. during the quarter that ended on 09/30. His purchase prices were between $10.25 and $21.61, with an estimated average price of $15.4. Since then the prices of USEC Inc. shares have declined by -46% from the estimated average. John Keeley owned 12,000 shares of as of 09/30, which is less than 0.01% of the $8.95 billion portfolio of Keeley Fund Management.
USEC, Inc., together with its subsidiaries, supplies low enriched uranium (LEU) for commercial nuclear power plants worldwide. It sells separative work units (SWU) component of LEU, the SWU and uranium components of LEU, and uranium. USEC Inc. has a market cap of $746.66 million; its shares were traded at around $8.26 with P/E ratio of 9.80 and P/S ratio of 0.44.
Last Wednesday, USEC, Inc. won a $400 million contract with Korean Hydro & Nuclear Power Co, LTD. The deal, effective until 2013, will boost the company’s revenues.
Irving Kahn, who owns 32,910 shares as of 06/30, reduced his position in USU. This is a decrease of 82.73% of from the previous quarter. His position accounts for 0.1% of the $709 million portfolio of Kahn Brothers & Company Inc.
Arnold Van Den Berg sold out his holdings in the quarter ended 06/30.
Angiotech Pharmaceuticals Inc. (ANPI): Down 33% Since John Keeley Bought In the Third Quarter
John Keeley initiated holdings in Pharmaceuticals company Angiotech Pharmaceuticals Inc. during the quarter ended 09/30. His purchase prices were between $5.72 and $7.27, with an estimated average price of $6.5. Since then the prices of Angiotech Pharmaceuticals Inc. shares have declined by -33% from the estimated average. John Keeley owned 26,970 shares of as of 09/30, which is less than 0.01% of the $8.95 billion portfolio of Keeley Fund Management.
Angiotech Pharmaceuticals, Inc. operates as a specialty pharmaceutical and medical device company. It discovers, develops, and markets technologies and medical products for local diseases and complications associated with medical device implants. ANPI develops drugs used to coat stents developed by Boston Scientific Corp, its partner company. Angiotech Pharmaceuticals Inc. has a market cap of $383.41 million; its shares were traded at around $4.38 with P/S ratio of 1.14.
ANPI stock is currently one of the biggest losers in the health industry. In the past 10 years, ANPI hit its record low. ANPIlost one-third of its market value after its partner company, Boston Scientific Corp., had a sales drop in the third quarter.
Both John Keeley and George Soros initiated their positions with ANPI. George Soros bought 28,211 shares in the quarter ended 06/30, which is 0.01% of the $3.15 billion portfolio of Soros Fund Management LLC.
Stein Mart Inc. (SMRT): Down 32% Since John Keeley Bought In the Third Quarter
John Keeley initiated holdings in Apparel Retailer Stein Mart Inc. during the quarter ended 09/30. His purchase prices were between $7.61 and $12.61, with an estimated average price of $9.7. Since then the prices of Stein Mart Inc. shares have declined by -32% from the estimated average. John Keeley owned 40,660 shares of as of 09/30.
Stein Mart, Inc. operates retail stores that offer fashion merchandises. It primarily offers branded apparel for women and men, as well as accessories, gifts, linen, and shoes. Stein Mart Inc. has a market cap of $279.80 million; its shares were traded at around $6.57 with P/E ratio of 9.08 and P/S ratio of 0.19. The dividend yield of Stein Mart Inc. stocks is 3.7%
SMRT stock has been on a downward slide in the past 2 years. An example of the company’s roller coaster performance: early 2007, sales were up by 7.3%, and second quarter, a 74% plunge. Still, SMRT will continue to expand its business by 10 more stores before November passes by.
Two Gurus Initiated Positions in SMRT: 1) John Keeley bought 40,660 shares in the quarter ended 09/30, which is less than 0.01% of the $8.95 billion portfolio of Keeley Fund Management. 2) Robert Olstein bought 23,000 shares in the quarter ended 06/30, which is 0.01% of the $1.92 billion portfolio of Olstein Financial Alert Fund.
One Guru Kept His Position in SMRT Unchanged or Slightly Adjusted: Arnold Schneider owns 847,775 shares as of 06/30, which accounts for 0.24% of the $4.37 billion portfolio of Schneider Capital Management.
George Soros sold out his holdings in the quarter ended 06/30.
Ruby Tuesday Inc. (RT): Down 31% Since John Keeley Bought In the Third Quarter 09/30/2007
John Keeley initiated holdings in restaurants chain Ruby Tuesday Inc. during the quarter ended 09/30. His purchase prices were between $18.34 and $26.61, with an estimated average price of $22.4. Since then the prices of Ruby Tuesday Inc. shares have declined by -31% from the estimated average. John Keeley owned 16,805 shares of as of 09/30, which is less than 0.01% of the $8.95 billion portfolio of Keeley Fund Management.
Ruby Tuesday, Inc., together with its subsidiaries, engages in the development, operation, and franchise of casual dining restaurants under the Ruby Tuesday brand name in the United States and internationally. Ruby Tuesday Inc. has a market cap of $783.24 million; its shares were traded at around $15.46 with P/E ratio of 10.47 and P/S ratio of 0.56. The dividend yield of Ruby Tuesday Inc. stocks is 3.2%
Ruby Tuesday had a 4.8% decline in sales in the third quarter due to competition with cheaper fast food chains. Early in the year, RT featured a healthy menu with fresh look, and a higher price. As a result, the customers did not respond well, and the company’s profit dropped by 49% in the first quarter. RT plans to lower prices for lunches to under $10 to gain customers.
David Dreman owns 155,900 shares as of 06/30, an increase of 328.3% from the previous quarter. This position accounts for 0.02% of the $19.55 billion portfolio of Dreman Value Management.
RT has seen as series buys from its directors. 1) Director Stephen I. Sadove bought a total of 50,000 shares at $15.75 on 10/15. 2) VP of Investor Relations & Planning, Shannon Hepp, bought 1300 shares on 10/16 at $15.19. 3) Director Bernard Jr. Lanigan bought a total of 118,397 shares at price range of $15.75 and $16.08 on 10/12.
Wabash National Corp. (WNC): Down 22% Since John Keeley Bought In the Third Quarter 09/30/2007
John Keeley initiated holdings in Commercial Vehicles & Trucks company Wabash National Corp. during the quarter ended 09/30. His purchase prices were between $11.29 and $14.67, with an estimated average price of $13. Since then the prices of Wabash National Corp. shares have declined by -22% from the estimated average. John Keeley owned 26,400 shares of as of 09/30.
Wabash National Corporation engages in the design, manufacture, and marketing of standard and customized truck trailers and related transportation equipment in North America. Wabash National Corp. has a market cap of $306.70 million; its shares were traded at around $10.18 with P/E ratio of 45.38 and P/S ratio of 0.24. The dividend yield of Wabash National Corp. stocks is 1.8%.
At the end of September, one of WNC’s products, DuraPlate ® dry van trailer gained the EPA’s SmartWay ® certification—certification process that encourages energy efficiency and greenhouse gas emission reduction.
Three Gurus Initiated Positions in WNC:1) John Keeley bought 26,400 shares in the quarter ended 09/30, which is less than 0.01% of the $8.95 billion portfolio of Keeley Fund Management. 2) George Soros bought 11,228 shares in the quarter ended 06/30, which is 0.01% of the $3.15 billion portfolio of Soros Fund Management LLC. 3) Arnold Schneider bought 10,000 shares in the quarter ended 06/30, which is less than 0.01% of the $4.37 billion portfolio of Schneider Capital Management.
Charles Brandes owns 550,020 shares as of 09/30, which accounts for 0.01% of the $54.32 billion portfolio of Brandes Investment.
President & CEO Richard J. Giromini bought WNC stock on two occasions: 5,000 shares on 08/02 at $12.50; and 5,000 more shares on 05/31 at $14.82.
USEC Inc. (USU): Down 46% Since John Keeley Bought In the Third Quarter
John Keeley initiated holdings in Electricity company USEC Inc. during the quarter that ended on 09/30. His purchase prices were between $10.25 and $21.61, with an estimated average price of $15.4. Since then the prices of USEC Inc. shares have declined by -46% from the estimated average. John Keeley owned 12,000 shares of as of 09/30, which is less than 0.01% of the $8.95 billion portfolio of Keeley Fund Management.
USEC, Inc., together with its subsidiaries, supplies low enriched uranium (LEU) for commercial nuclear power plants worldwide. It sells separative work units (SWU) component of LEU, the SWU and uranium components of LEU, and uranium. USEC Inc. has a market cap of $746.66 million; its shares were traded at around $8.26 with P/E ratio of 9.80 and P/S ratio of 0.44.
Last Wednesday, USEC, Inc. won a $400 million contract with Korean Hydro & Nuclear Power Co, LTD. The deal, effective until 2013, will boost the company’s revenues.
Irving Kahn, who owns 32,910 shares as of 06/30, reduced his position in USU. This is a decrease of 82.73% of from the previous quarter. His position accounts for 0.1% of the $709 million portfolio of Kahn Brothers & Company Inc.
Arnold Van Den Berg sold out his holdings in the quarter ended 06/30.
Angiotech Pharmaceuticals Inc. (ANPI): Down 33% Since John Keeley Bought In the Third Quarter
John Keeley initiated holdings in Pharmaceuticals company Angiotech Pharmaceuticals Inc. during the quarter ended 09/30. His purchase prices were between $5.72 and $7.27, with an estimated average price of $6.5. Since then the prices of Angiotech Pharmaceuticals Inc. shares have declined by -33% from the estimated average. John Keeley owned 26,970 shares of as of 09/30, which is less than 0.01% of the $8.95 billion portfolio of Keeley Fund Management.
Angiotech Pharmaceuticals, Inc. operates as a specialty pharmaceutical and medical device company. It discovers, develops, and markets technologies and medical products for local diseases and complications associated with medical device implants. ANPI develops drugs used to coat stents developed by Boston Scientific Corp, its partner company. Angiotech Pharmaceuticals Inc. has a market cap of $383.41 million; its shares were traded at around $4.38 with P/S ratio of 1.14.
ANPI stock is currently one of the biggest losers in the health industry. In the past 10 years, ANPI hit its record low. ANPIlost one-third of its market value after its partner company, Boston Scientific Corp., had a sales drop in the third quarter.
Both John Keeley and George Soros initiated their positions with ANPI. George Soros bought 28,211 shares in the quarter ended 06/30, which is 0.01% of the $3.15 billion portfolio of Soros Fund Management LLC.
Stein Mart Inc. (SMRT): Down 32% Since John Keeley Bought In the Third Quarter
John Keeley initiated holdings in Apparel Retailer Stein Mart Inc. during the quarter ended 09/30. His purchase prices were between $7.61 and $12.61, with an estimated average price of $9.7. Since then the prices of Stein Mart Inc. shares have declined by -32% from the estimated average. John Keeley owned 40,660 shares of as of 09/30.
Stein Mart, Inc. operates retail stores that offer fashion merchandises. It primarily offers branded apparel for women and men, as well as accessories, gifts, linen, and shoes. Stein Mart Inc. has a market cap of $279.80 million; its shares were traded at around $6.57 with P/E ratio of 9.08 and P/S ratio of 0.19. The dividend yield of Stein Mart Inc. stocks is 3.7%
SMRT stock has been on a downward slide in the past 2 years. An example of the company’s roller coaster performance: early 2007, sales were up by 7.3%, and second quarter, a 74% plunge. Still, SMRT will continue to expand its business by 10 more stores before November passes by.
Two Gurus Initiated Positions in SMRT: 1) John Keeley bought 40,660 shares in the quarter ended 09/30, which is less than 0.01% of the $8.95 billion portfolio of Keeley Fund Management. 2) Robert Olstein bought 23,000 shares in the quarter ended 06/30, which is 0.01% of the $1.92 billion portfolio of Olstein Financial Alert Fund.
One Guru Kept His Position in SMRT Unchanged or Slightly Adjusted: Arnold Schneider owns 847,775 shares as of 06/30, which accounts for 0.24% of the $4.37 billion portfolio of Schneider Capital Management.
George Soros sold out his holdings in the quarter ended 06/30.
Ruby Tuesday Inc. (RT): Down 31% Since John Keeley Bought In the Third Quarter 09/30/2007
John Keeley initiated holdings in restaurants chain Ruby Tuesday Inc. during the quarter ended 09/30. His purchase prices were between $18.34 and $26.61, with an estimated average price of $22.4. Since then the prices of Ruby Tuesday Inc. shares have declined by -31% from the estimated average. John Keeley owned 16,805 shares of as of 09/30, which is less than 0.01% of the $8.95 billion portfolio of Keeley Fund Management.
Ruby Tuesday, Inc., together with its subsidiaries, engages in the development, operation, and franchise of casual dining restaurants under the Ruby Tuesday brand name in the United States and internationally. Ruby Tuesday Inc. has a market cap of $783.24 million; its shares were traded at around $15.46 with P/E ratio of 10.47 and P/S ratio of 0.56. The dividend yield of Ruby Tuesday Inc. stocks is 3.2%
Ruby Tuesday had a 4.8% decline in sales in the third quarter due to competition with cheaper fast food chains. Early in the year, RT featured a healthy menu with fresh look, and a higher price. As a result, the customers did not respond well, and the company’s profit dropped by 49% in the first quarter. RT plans to lower prices for lunches to under $10 to gain customers.
David Dreman owns 155,900 shares as of 06/30, an increase of 328.3% from the previous quarter. This position accounts for 0.02% of the $19.55 billion portfolio of Dreman Value Management.
RT has seen as series buys from its directors. 1) Director Stephen I. Sadove bought a total of 50,000 shares at $15.75 on 10/15. 2) VP of Investor Relations & Planning, Shannon Hepp, bought 1300 shares on 10/16 at $15.19. 3) Director Bernard Jr. Lanigan bought a total of 118,397 shares at price range of $15.75 and $16.08 on 10/12.
Wabash National Corp. (WNC): Down 22% Since John Keeley Bought In the Third Quarter 09/30/2007
John Keeley initiated holdings in Commercial Vehicles & Trucks company Wabash National Corp. during the quarter ended 09/30. His purchase prices were between $11.29 and $14.67, with an estimated average price of $13. Since then the prices of Wabash National Corp. shares have declined by -22% from the estimated average. John Keeley owned 26,400 shares of as of 09/30.
Wabash National Corporation engages in the design, manufacture, and marketing of standard and customized truck trailers and related transportation equipment in North America. Wabash National Corp. has a market cap of $306.70 million; its shares were traded at around $10.18 with P/E ratio of 45.38 and P/S ratio of 0.24. The dividend yield of Wabash National Corp. stocks is 1.8%.
At the end of September, one of WNC’s products, DuraPlate ® dry van trailer gained the EPA’s SmartWay ® certification—certification process that encourages energy efficiency and greenhouse gas emission reduction.
Three Gurus Initiated Positions in WNC:1) John Keeley bought 26,400 shares in the quarter ended 09/30, which is less than 0.01% of the $8.95 billion portfolio of Keeley Fund Management. 2) George Soros bought 11,228 shares in the quarter ended 06/30, which is 0.01% of the $3.15 billion portfolio of Soros Fund Management LLC. 3) Arnold Schneider bought 10,000 shares in the quarter ended 06/30, which is less than 0.01% of the $4.37 billion portfolio of Schneider Capital Management.
Charles Brandes owns 550,020 shares as of 09/30, which accounts for 0.01% of the $54.32 billion portfolio of Brandes Investment.
President & CEO Richard J. Giromini bought WNC stock on two occasions: 5,000 shares on 08/02 at $12.50; and 5,000 more shares on 05/31 at $14.82.
